Benefits of Trimetazidine in MAFLD Pateints

Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: conventional treatment; Drug: Furosemide or other alternatives , Niaspan or other alternatives; Drug: Trimetazidine Sponsors: October 6 University Recruiting

https://clinicaltrials.gov/study/NCT06140953

Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials